Haemato Oncology Testing Market, Global Outlook and Forecast 2022-2028

August 2022 | 68 pages | ID: HF54ED8758A1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Haemato Oncology Testing in Global, including the following market information:

Global Haemato Oncology Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Haemato Oncology Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Leukaemia Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Haemato Oncology Testing include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber and YZY Biopharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Haemato Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Haemato Oncology Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Haemato Oncology Testing Market Segment Percentages, by Type, 2021 (%)

• Leukaemia
• Lymphoma
• Hodgkin Lymphoma
• Others

Global Haemato Oncology Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Haemato Oncology Testing Market Segment Percentages, by Application, 2021 (%)

• Clinical Laboratories
• Hospitals
• Academic and Research Institutes
• Others

Global Haemato Oncology Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Haemato Oncology Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Haemato Oncology Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Haemato Oncology Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Berry Genomics
• Burning Rock Dx
• BGI
• Genetron
• Haplox
• Amoy Dx
• Genosaber
• YZY Biopharma
• Wondfo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Haemato Oncology Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Haemato Oncology Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HAEMATO ONCOLOGY TESTING OVERALL MARKET SIZE

2.1 Global Haemato Oncology Testing Market Size: 2021 VS 2028
2.2 Global Haemato Oncology Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Haemato Oncology Testing Players in Global Market
3.2 Top Global Haemato Oncology Testing Companies Ranked by Revenue
3.3 Global Haemato Oncology Testing Revenue by Companies
3.4 Top 3 and Top 5 Haemato Oncology Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Haemato Oncology Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Haemato Oncology Testing Players in Global Market
  3.6.1 List of Global Tier 1 Haemato Oncology Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Haemato Oncology Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Haemato Oncology Testing Market Size Markets, 2021 & 2028
  4.1.2 Leukaemia
  4.1.3 Lymphoma
  4.1.4 Hodgkin Lymphoma
  4.1.5 Others
4.2 By Type - Global Haemato Oncology Testing Revenue & Forecasts
  4.2.1 By Type - Global Haemato Oncology Testing Revenue, 2017-2022
  4.2.2 By Type - Global Haemato Oncology Testing Revenue, 2023-2028
  4.2.3 By Type - Global Haemato Oncology Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Haemato Oncology Testing Market Size, 2021 & 2028
  5.1.2 Clinical Laboratories
  5.1.3 Hospitals
  5.1.4 Academic and Research Institutes
  5.1.5 Others
5.2 By Application - Global Haemato Oncology Testing Revenue & Forecasts
  5.2.1 By Application - Global Haemato Oncology Testing Revenue, 2017-2022
  5.2.2 By Application - Global Haemato Oncology Testing Revenue, 2023-2028
  5.2.3 By Application - Global Haemato Oncology Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Haemato Oncology Testing Market Size, 2021 & 2028
6.2 By Region - Global Haemato Oncology Testing Revenue & Forecasts
  6.2.1 By Region - Global Haemato Oncology Testing Revenue, 2017-2022
  6.2.2 By Region - Global Haemato Oncology Testing Revenue, 2023-2028
  6.2.3 By Region - Global Haemato Oncology Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Haemato Oncology Testing Revenue, 2017-2028
  6.3.2 US Haemato Oncology Testing Market Size, 2017-2028
  6.3.3 Canada Haemato Oncology Testing Market Size, 2017-2028
  6.3.4 Mexico Haemato Oncology Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Haemato Oncology Testing Revenue, 2017-2028
  6.4.2 Germany Haemato Oncology Testing Market Size, 2017-2028
  6.4.3 France Haemato Oncology Testing Market Size, 2017-2028
  6.4.4 U.K. Haemato Oncology Testing Market Size, 2017-2028
  6.4.5 Italy Haemato Oncology Testing Market Size, 2017-2028
  6.4.6 Russia Haemato Oncology Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Haemato Oncology Testing Market Size, 2017-2028
  6.4.8 Benelux Haemato Oncology Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Haemato Oncology Testing Revenue, 2017-2028
  6.5.2 China Haemato Oncology Testing Market Size, 2017-2028
  6.5.3 Japan Haemato Oncology Testing Market Size, 2017-2028
  6.5.4 South Korea Haemato Oncology Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Haemato Oncology Testing Market Size, 2017-2028
  6.5.6 India Haemato Oncology Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Haemato Oncology Testing Revenue, 2017-2028
  6.6.2 Brazil Haemato Oncology Testing Market Size, 2017-2028
  6.6.3 Argentina Haemato Oncology Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Haemato Oncology Testing Revenue, 2017-2028
  6.7.2 Turkey Haemato Oncology Testing Market Size, 2017-2028
  6.7.3 Israel Haemato Oncology Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Haemato Oncology Testing Market Size, 2017-2028
  6.7.5 UAE Haemato Oncology Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Haemato Oncology Testing Major Product Offerings
  7.1.4 Roche Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Berry Genomics
  7.2.1 Berry Genomics Corporate Summary
  7.2.2 Berry Genomics Business Overview
  7.2.3 Berry Genomics Haemato Oncology Testing Major Product Offerings
  7.2.4 Berry Genomics Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.2.5 Berry Genomics Key News
7.3 Burning Rock Dx
  7.3.1 Burning Rock Dx Corporate Summary
  7.3.2 Burning Rock Dx Business Overview
  7.3.3 Burning Rock Dx Haemato Oncology Testing Major Product Offerings
  7.3.4 Burning Rock Dx Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.3.5 Burning Rock Dx Key News
7.4 BGI
  7.4.1 BGI Corporate Summary
  7.4.2 BGI Business Overview
  7.4.3 BGI Haemato Oncology Testing Major Product Offerings
  7.4.4 BGI Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.4.5 BGI Key News
7.5 Genetron
  7.5.1 Genetron Corporate Summary
  7.5.2 Genetron Business Overview
  7.5.3 Genetron Haemato Oncology Testing Major Product Offerings
  7.5.4 Genetron Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.5.5 Genetron Key News
7.6 Haplox
  7.6.1 Haplox Corporate Summary
  7.6.2 Haplox Business Overview
  7.6.3 Haplox Haemato Oncology Testing Major Product Offerings
  7.6.4 Haplox Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.6.5 Haplox Key News
7.7 Amoy Dx
  7.7.1 Amoy Dx Corporate Summary
  7.7.2 Amoy Dx Business Overview
  7.7.3 Amoy Dx Haemato Oncology Testing Major Product Offerings
  7.7.4 Amoy Dx Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.7.5 Amoy Dx Key News
7.8 Genosaber
  7.8.1 Genosaber Corporate Summary
  7.8.2 Genosaber Business Overview
  7.8.3 Genosaber Haemato Oncology Testing Major Product Offerings
  7.8.4 Genosaber Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.8.5 Genosaber Key News
7.9 YZY Biopharma
  7.9.1 YZY Biopharma Corporate Summary
  7.9.2 YZY Biopharma Business Overview
  7.9.3 YZY Biopharma Haemato Oncology Testing Major Product Offerings
  7.9.4 YZY Biopharma Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.9.5 YZY Biopharma Key News
7.10 Wondfo
  7.10.1 Wondfo Corporate Summary
  7.10.2 Wondfo Business Overview
  7.10.3 Wondfo Haemato Oncology Testing Major Product Offerings
  7.10.4 Wondfo Haemato Oncology Testing Revenue in Global Market (2017-2022)
  7.10.5 Wondfo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Haemato Oncology Testing Market Opportunities & Trends in Global Market
Table 2. Haemato Oncology Testing Market Drivers in Global Market
Table 3. Haemato Oncology Testing Market Restraints in Global Market
Table 4. Key Players of Haemato Oncology Testing in Global Market
Table 5. Top Haemato Oncology Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Haemato Oncology Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Haemato Oncology Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Haemato Oncology Testing Product Type
Table 9. List of Global Tier 1 Haemato Oncology Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemato Oncology Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Haemato Oncology Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Haemato Oncology Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Haemato Oncology Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Haemato Oncology Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Haemato Oncology Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Haemato Oncology Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Haemato Oncology Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Haemato Oncology Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Haemato Oncology Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Haemato Oncology Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Haemato Oncology Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Haemato Oncology Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Haemato Oncology Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Haemato Oncology Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Haemato Oncology Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Haemato Oncology Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Haemato Oncology Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Haemato Oncology Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Haemato Oncology Testing Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Haemato Oncology Testing Product Offerings
Table 32. Roche Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 33. Berry Genomics Corporate Summary
Table 34. Berry Genomics Haemato Oncology Testing Product Offerings
Table 35. Berry Genomics Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 36. Burning Rock Dx Corporate Summary
Table 37. Burning Rock Dx Haemato Oncology Testing Product Offerings
Table 38. Burning Rock Dx Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 39. BGI Corporate Summary
Table 40. BGI Haemato Oncology Testing Product Offerings
Table 41. BGI Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 42. Genetron Corporate Summary
Table 43. Genetron Haemato Oncology Testing Product Offerings
Table 44. Genetron Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 45. Haplox Corporate Summary
Table 46. Haplox Haemato Oncology Testing Product Offerings
Table 47. Haplox Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 48. Amoy Dx Corporate Summary
Table 49. Amoy Dx Haemato Oncology Testing Product Offerings
Table 50. Amoy Dx Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 51. Genosaber Corporate Summary
Table 52. Genosaber Haemato Oncology Testing Product Offerings
Table 53. Genosaber Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 54. YZY Biopharma Corporate Summary
Table 55. YZY Biopharma Haemato Oncology Testing Product Offerings
Table 56. YZY Biopharma Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)
Table 57. Wondfo Corporate Summary
Table 58. Wondfo Haemato Oncology Testing Product Offerings
Table 59. Wondfo Haemato Oncology Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Haemato Oncology Testing Segment by Type in 2021
Figure 2. Haemato Oncology Testing Segment by Application in 2021
Figure 3. Global Haemato Oncology Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Haemato Oncology Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Haemato Oncology Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Haemato Oncology Testing Revenue in 2021
Figure 8. By Type - Global Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 12. US Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 16. Germany Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 24. China Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Haemato Oncology Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Haemato Oncology Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Berry Genomics Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Burning Rock Dx Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BGI Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genetron Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Haplox Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Amoy Dx Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Genosaber Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. YZY Biopharma Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Wondfo Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)